Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fruitflow®+ is a dietary supplement developed by Provexis plc that combines a patented water-soluble tomato extract (Fruitflow®) with omega-3 fatty acids (EPA and DHA) to support cardiovascular health. The Fruitflow® component contains over 30 antiplatelet compounds derived from the jelly surrounding tomato seeds, which work to inhibit excessive platelet aggregation and activation. This mechanism helps maintain healthy blood flow without the side effects typically associated with antiplatelet drugs like aspirin. It is the first natural ingredient to receive a positive scientific opinion from the European Food Safety Authority (EFSA) for its role in maintaining normal platelet aggregation. The product is formulated as an oral capsule containing 150mg of Fruitflow and 250mg of omega-3.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fruitflow®+.